2020 Drug Design and Delivery Symposium

We are planning a diverse set of broadcasts for this year’s symposium and will feature the most innovative and revolutionary ideas in drug design and delivery. The details for upcoming broadcasts will be posted as they are finalized.

Mar 19	Passive Permeability: An Important Mechanism for Drug Absorption Li Di - Pfizer Faraj Atassi - AstraZeneca
Apr 15	COVID-19: A Groundwork for Therapeutic Agents and Vaccines Qiongqiong Angela Zhou - CAS Dennis Liotta - Emory Institute for Drug Development
Apr 30	How Drugs Really Get Into Cells: Why Passive Bilayer Diffusion is a Myth Douglas Kell - University of Liverpool Mike Sinz - Bristol-Myers Squibb
May 28	mRNA Technology for Infectious Diseases: Therapeutic Applications and Vaccine Development Jim Thompson - Moderna, Inc. Venkat Krishnamurthy - Astrazeneca
Jun 25	Enabling Technologies for Revealing Druggable Paths in RNA Biology Amanda Garner - University of Michigan Matt Disney - The Scripps Research Institute
Jul 30	Nature’s Dirty Little Secret: The Diverted Total Syntheses of Rhizosphere Natural Products as Targeted Antibacterial Agents Bill Wuest - Emory University Cassandra Quave - Emory University School of Medicine
Sep 23	Mitragyna Speciosa: What Science is Telling Us about Kratom Christopher McCurdy - College of Pharmacy, University of Florida Amy Newman - NIDA-Intramural Research Program, National Institutes of Health
Oct 29	Mitigating Drug-Induced Liver Injury: Assessing Mitochondrial Toxicity and Reactive Metabolism Yvonne Will - Janssen Pharmaceutical Kevin Coe - Janssen Pharmaceutical Kaushik Mitra - Janssen Research & Development
Nov 19	Mitigating Drug-Induced Liver Injury 2: Assessing Transporter Liabilities and Bioactivation Transcriptomics Michael Hafey - Merck Jim Monroe - Merck Wen Kang - Merck Kaushik Mitra - Janssen Research & Development